Transient cortical blindness secondary to vincristine therapy in childhood malignancies
- 1 January 1981
Abstract
Three children with malignancies developed severe neurotoxicity, including transient cortical blindness, following chemotherapy regimens. The only drug in common was vincristine sulfate. The clinical courses of these patient are described. All have completely recovered, although one child who was rechallenged with vincristine had a cardiorespiratory arrest, increasing neurotoxicity, and recurrence of blindness. Transient cortical blindness has not previously been attributed to vincristine sulfate therapy, but must be considered as a possible complication of treatment with this agent.This publication has 24 references indexed in Scilit:
- The effects of cancer therapy on the nervous systemThe Journal of Pediatrics, 1978
- Cortical blindness as a complication of hemodialysisThe Journal of Pediatrics, 1978
- Overdosage with vincristineThe Journal of Pediatrics, 1976
- Vincristine toxicity unrelated to dose.Archives of Disease in Childhood, 1976
- Seizures associated with vincristine sulfate therapyThe Journal of Pediatrics, 1973
- Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level)The Journal of Pediatrics, 1972
- The neuromyopathy of vincristine in manJournal of the Neurological Sciences, 1970
- Vincristine neuropathy: an electrophysiological and histological study.Journal of Neurology, Neurosurgery & Psychiatry, 1969
- Ocular Complications of Vincristine TherapyArchives of Ophthalmology (1950), 1967
- Neuropathy in Lymphoblastic Leukemia Treated With VincristineArchives of Neurology, 1967